CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Non-Invasive Bone Conduction Devices for Conductive Hearing Loss: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Last updated: November 12, 2019
Project Number: RB1410-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of non-invasive bone conduction hearing devices for patients with unilateral or bilateral conductive hearing loss?
  2. What is the cost-effectiveness of non-invasive bone conduction hearing devices for patients with unilateral or bilateral conductive hearing loss?
  3. What are the evidence-based guidelines regarding the use of non-invasive bone conduction hearing devices for patients with unilateral or bilateral conductive hearing loss?

Key Message

One randomized controlled trial and four non-randomized studies were identified regarding the clinical effectiveness of non-invasive bone conduction hearing devices for patients with unilateral or bilateral conductive hearing loss. Additionally, no relevant economic evaluations or evidence-based guidelines were identified regarding the cost-effectiveness and use of non-invasive bone conduction hearing devices for patients with unilateral or bilateral conductive hearing loss.